Literature DB >> 29405466

Prediction of carotid intima-media thickness in obese patients with low prevalence of comorbidities by serum copper bioavailability.

Giovanni Tarantino1, Cristiana Porcu2,3, Mario Arciello2,3, Paola Andreozzi2,3, Clara Balsano2,3.   

Abstract

BACKGROUND AND AIM: Western societies, with growing prevalence, suffer from various metabolic diseases like obesity and hepatic steatosis, better defined as non-alcoholic fatty liver disease, or cardiovascular (CV) diseases that are strictly linked to each other. The association of their occurrence with the altered homeostasis of metals is an intriguing issue. Copper in particular was identified as key player in various metabolic derangements. On these bases, we aimed at investigating the possible association of serum copper levels with an indicator of early CV risk as the intima-media thickness (IMT) of carotid artery and its predictive value in a selected population of obese patients.
METHODS: We performed a cross-sectional study recruiting 100 obese patients characterized by a low prevalence of comorbidities. Ultrasound investigation for hepatic steatosis and IMT evaluation were performed. Serum samples were collected and then analyzed through atomic absorption spectrometry to evaluate their copper content. Possible correlations between copper bioavailability and biochemical, clinical, and anthropometric characteristics of patients were sought.
RESULTS: Age negatively predicted copper serum levels of patients (P = 0.009). However, the most interesting finding is the negative prediction of IMT by the copper serum levels (t = -2.23, P = 0.028, least absolute deviations regression). Factor analysis confirmed the aforementioned inverse correlation and highlighted the strong inverse correlation between smoking and copper serum levels.
CONCLUSION: Our data show that an altered copper bioavailability predicts early atherosclerosis as main CV risk in obese patients with hepatic steatosis detected by ultrasound, shedding some light in this pathological scenario.
© 2018 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  cardiovascular risk; copper; hepatic steatosis; intima-media thickness; obesity

Mesh:

Substances:

Year:  2018        PMID: 29405466     DOI: 10.1111/jgh.14104

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

Review 1.  Nonalcoholic fatty liver disease and alcoholic liver disease: metabolic diseases with systemic manifestations.

Authors:  Alexander J Kovalic; George Cholankeril; Sanjaya K Satapathy
Journal:  Transl Gastroenterol Hepatol       Date:  2019-09-03

Review 2.  Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

Authors:  Hannah K Drescher; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Cells       Date:  2019-08-07       Impact factor: 6.600

3.  Fatty liver is a risk factor for liver metastasis in Chinese patients with non-small cell lung cancer.

Authors:  Wenyu Wu; Haiyan Liao; Weilin Ye; Xi Li; Jian Zhang; Junguo Bu
Journal:  PeerJ       Date:  2019-03-14       Impact factor: 2.984

4.  Influence of endurance and endurance-strength training on mineral status in women with abdominal obesity: a randomized trial.

Authors:  Damian Skrypnik; Paweł Bogdański; Katarzyna Skrypnik; Edyta Mądry; Joanna Karolkiewicz; Monika Szulińska; Joanna Suliburska; Jarosław Walkowiak
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

5.  Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways.

Authors:  Chun-Xiao Li; Jian-Guo Gao; Xing-Yong Wan; Yi Chen; Cheng-Fu Xu; Ze-Min Feng; Hang Zeng; Yi-Ming Lin; Han Ma; Ping Xu; Chao-Hui Yu; You-Ming Li
Journal:  World J Gastroenterol       Date:  2019-09-14       Impact factor: 5.742

Review 6.  A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).

Authors:  Manca Povsic; On Yee Wong; Richard Perry; Juliana Bottomley
Journal:  Adv Ther       Date:  2019-05-07       Impact factor: 3.845

Review 7.  A Recent Achievement In the Discovery and Development of Novel Targets for the Treatment of Type-2 Diabetes Mellitus.

Authors:  Tafere Mulaw Belete
Journal:  J Exp Pharmacol       Date:  2020-01-10

Review 8.  Macrophage Function in the Pathogenesis of Non-alcoholic Fatty Liver Disease: The Mac Attack.

Authors:  Jarren R Oates; Melanie C McKell; Maria E Moreno-Fernandez; Michelle S M A Damen; George S Deepe; Joseph E Qualls; Senad Divanovic
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

9.  Do Flavonoids from Durum Wheat Contribute to Its Bioactive Properties? A Prospective Study.

Authors:  Adriano Costa de Camargo; Anna Paula de Souza Silva; Jackeline Cintra Soares; Severino Matias de Alencar; Cíntia Ladeira Handa; Karina Silva Cordeiro; Marcela Souza Figueira; Geni R Sampaio; Elizabeth A F S Torres; Fereidoon Shahidi; Andrés R Schwember
Journal:  Molecules       Date:  2021-01-17       Impact factor: 4.411

10.  Association between dietary iron intake and the prevalence of nonalcoholic fatty liver disease: A cross-sectional study.

Authors:  Zidan Yang; Jing Wu; Xiaoxiao Li; Dongxing Xie; Yilun Wang; Tubao Yang
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.